BNP Paribas Asset Management’s Surgery Partners SGRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.3K Sell
735
-505
-41% -$7.09K ﹤0.01% 2166
2026
Q1
$14.8K Buy
1,240
+324
+35% +$4.65K ﹤0.01% 2114
2025
Q4
$14K Buy
916
+234
+34% +$4.3K ﹤0.01% 2055
2025
Q3
$15K Hold
682
– – ﹤0.01% 1505
2025
Q2
$15K Buy
+682
New +$15.2K ﹤0.01% 1626

Other funds holding SGRY

BNP Paribas Asset Management's SGRY Position: Q2 2026 in Review

BNP Paribas Asset Management reduced its Surgery Partners (SGRY) stake by 41% in Q2 2026, selling an estimated $7.09K and leaving 735 shares worth $12.3K. The position accounts for ﹤0.01% of the portfolio, ranked #2166.

BNP Paribas Asset Management first reported a position in SGRY in Q2 2025 and has held it in 5 quarters since. The position peaked at $15K in Q3 2025. 187 funds tracked by Wall St. Rank hold SGRY as of Q2 2026.

  • BNP Paribas Asset Management held 735 shares of Surgery Partners worth $12.3K as of Q2 2026.
  • BNP Paribas Asset Management sold 505 Surgery Partners shares in Q2 2026, an estimated $7.09K.
  • Surgery Partners made up ﹤0.01% of BNP Paribas Asset Management's portfolio in Q2 2026, its #2166 holding.
  • BNP Paribas Asset Management first reported a position in Surgery Partners in Q2 2025 and has held it in 5 quarters since.
  • BNP Paribas Asset Management's Surgery Partners position peaked at $15K in Q3 2025.
  • 187 funds tracked by Wall St. Rank held Surgery Partners as of Q2 2026.

Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.